• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Breast cancer research and treatment. >A population-based recurrence risk management study of patients with pT1 node-negative HER2+breast cancer: a National Clinical Database study
【24h】

A population-based recurrence risk management study of patients with pT1 node-negative HER2+breast cancer: a National Clinical Database study

机译：PT1节点阴性HER2 +乳腺癌患者的患者的基于人群的复发风险管理研究：国家临床数据库研究

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose Recurrence risk management of patients with small (<= 2 cm), node-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer remains challenging. We studied the effects of adjuvant chemotherapy and/or trastuzumab and survival outcomes among these patients, using data from the population-based Japanese National Clinical Database (NCD).
机译：目的复发性风险管理小（<= 2cm），节点阴性，人体表皮生长因子受体2（HER2） - 阳性乳腺癌仍然具有挑战性。 我们研究了这些患者中辅助化疗和/或曲妥珠单抗和生存结果的影响，使用来自群体的日本国家临床数据库（NCD）的数据。

著录项

  • 来源
  • 作者

    Kubo Makoto; Kawai Masaaki; Kumamaru Hiraku; Miyata Hiroaki; Tamura Kenji; Yoshida Masayuki; Ogo Etsuyo; Nagahashi Masayuki; Asaga Sota; Kojima Yasuyuki; Kadoya Takayuki; Aogi Kenjiro; Niikura Naoki; Miyashita Minoru; Iijima Kotaro; Hayashi Naoki; Yamamoto Yutaka; Imoto Shigeru; Jinno Hiromitsu;

  • 作者单位

    Kyushu Univ Grad Sch Med Sci Dept Surg &

    Oncol Higashi Ku 3-1-1 Maidashi Fukuoka 8128582 Japan;

    Miyagi Canc Ctr Hosp Dept Breast Oncol 47-1 Nodayama Natori Miyagi 9811293 Japan;

    Univ Tokyo Dept Healthcare Qual Assessment Bunkyo Ku 7-3-1 Hongo Tokyo 1138655 Japan;

    Univ Tokyo Dept Healthcare Qual Assessment Bunkyo Ku 7-3-1 Hongo Tokyo 1138655 Japan;

    Natl Canc Ctr Dept Breast &

    Med Oncol Chuo Ku 5-1-1 Tsukiji Tokyo 1040045 Japan;

    Natl Canc Ctr Dept Diagnost Pathol Chuo Ku 5-1-1 Tsukiji Tokyo 1040045 Japan;

    Kurume Univ Sch Med Dept Radiol 67 Asahi Machi Kurume Fukuoka 8300011 Japan;

    Niigata Univ Grad Sch Med &

    Dent Sci Div Digest &

    Gen Surg Chuo Ku 1-757 Asahimachi Dori;

    Kyorin Univ Sch Med Dept Breast Surg 6-20-2 Shinkawa Mitaka Tokyo 1818611 Japan;

    St Marianna Univ Sch Med Dept Surg Div Breast &

    Endocrine Surg Miyamae Ku 2-16-1 Sugao;

    Hiroshima Univ Res Inst Radiat Biol &

    Med Dept Surg Oncol Minami Ku 1-2-3 Kasumi Hiroshima;

    Natl Hosp Org Shikoku Canc Ctr Dept Breast Oncol Kou 160 Minamiumemotomachi Matsuyama Ehime;

    Tokai Univ Sch Med Dept Breast &

    Endocrine Surg 143 Shimokasuya Isehara Kanagawa 2591193 Japan;

    Tohoku Univ Sch Med Dept Breast &

    Endocrine Surg Oncol Aoba Ku Seiryo Machi Sendai Miyagi;

    Juntendo Univ Dept Breast Oncol Bunkyo Ku 3-1-3 Hongo Tokyo 1138431 Japan;

    St Lukes Int Hosp Dept Breast Surg Oncol Chuo Ku 9-1 Akashicho Tokyo 1048560 Japan;

    Kumamoto Univ Dept Mol Targeting Therapy Breast Canc Chuo Ku 1-1-1 Honjo Kumamoto 8608556 Japan;

    Kyorin Univ Hosp Dept Breast Surg 6-20-2 Shinkawa Mitaka Tokyo 1818611 Japan;

    Teikyo Univ Sch Med Dept Surg Itabashi Ku 2-11-1 Kaga Tokyo 1738606 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Breast cancer; Stage I; Human epidermal growth factor receptor 2; Chemotherapy; Trastuzumab;

    机译：乳腺癌;阶段I;人表皮生长因子受体2;化疗;曲妥珠单抗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号